TRAIL
Term · Oncology and biomedicine · MLC-T-ONC-008816
A cell protein that can attach to certain molecules in some cancer cells and may kill the cells. TRAIL is being studied in the treatment of cancer. Also called Apo-2L, TNF-related apoptosis-inducing ligand, and tumor necrosis factor-related apoptosis-inducing ligand.
| Identifier | MLC-T-ONC-008816 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | TNF-related apoptosis-inducing ligand; tumor necrosis factor-related apoptosis-inducing ligand |
| Synonyms | Apo-2L |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-008816",
"term": "TRAIL",
"field": "Oncology and biomedicine",
"definition": "A cell protein that can attach to certain molecules in some cancer cells and may kill the cells. TRAIL is being studied in the treatment of cancer. Also called Apo-2L, TNF-related apoptosis-inducing ligand, and tumor necrosis factor-related apoptosis-inducing ligand.",
"expansions": [
"TNF-related apoptosis-inducing ligand",
"tumor necrosis factor-related apoptosis-inducing ligand"
],
"synonyms": [
"Apo-2L"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/trail/"
}
Record 16,589 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.